MedTrace Logo

Short Running Head Obesity in Rectal Cancer Patients

NCT04759638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2021-02-18

No results posted yet for this study

Summary

There is a controversy regarding the effect of the two Body Mass Index (BMI) extremes on the oncological outcome of rectal cancer.

The obesity paradox appears to exist in rectal cancer patients treated with nCRT and surgery, as it was associated with significantly higher rates of pathological complete response and R0 resection.

Underweight patients were at higher risk for anastomotic leak and R1 resection.

Conditions

Sponsors & Collaborators

  • King Hussein Cancer Center

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-21
Primary Completion
2020-03-25
Completion
2020-03-25

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759638 on ClinicalTrials.gov